As of 2026-03-05, the Fair Value of Bristol-Myers Squibb Co (BMY) is 86.64 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 62.33 USD, the upside of Bristol-Myers Squibb Co is 39.00%.
With the market price of 62.33 USD and our fair value calculation, Bristol-Myers Squibb Co (BMY) is a good investment. Investing in Bmy stocks now will result in a potential gain of 39.00%.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 5Y Avg | |
| Net income | 6,994.00 | 6,327.00 | 8,025.00 | -8,948.00 | 7,054.00 | 3,890.40 |
| YoY growth | 177.58% | -9.54% | 26.84% | -211.50% | 178.83% | 32.44% |
| Market Cap (mil) | 126,888.30 |
| P/E | 17.99x |
| Forward P/E | 14.97x |
| EPS | 3.47 |
| Avg earnings growth rate | 32.44% |
| TTM earnings | 7,055.00 |